Nanox.arc imaging system receives fda clearance for general use, including pulmonary indication

Petach tikva, israel, dec. 05, 2024 (globe newswire) -- nano-x imaging ltd (“nanox” or the “company,” nasdaq: nnox), an innovative medical imaging technology company, today announced that it has received 510(k) clearance from the u.s. food and drug administration (fda) for its nanox.arc, a stationary x-ray system intended to produce tomographic images for general use including human musculoskeletal system, pulmonary, intra-abdominal, and paranasal sinus indications, adjunctive to conventional radiography, on adult patients.
ARC Ratings Summary
ARC Quant Ranking